0
Article |

TETRACYCLINE SPLENOMEGALY IN YOUNG RABBITS FREE

KITTY LITTLE, MA, D Phil; THOMAS EDGINGTON, MD
Am J Dis Child. 1963;106(5):521-522. doi:10.1001/archpedi.1963.02080050523025.
Text Size: A A A
Published online

To the Editor: The articles by Drs. Yadav et al in the March, 1963, (105:253) and Drs. Cohlan et al in the May, 1963, (105:453) issues of the American Journal of Diseases of Children are yet additional timely reminders of the possible toxic side effects of the commonly used tetracycline drugs. Increased awareness of occasional undesirable effects has prompted the inclusion of tetracyclines among the drugs discussed in the session on "Influence of Drugs on the Human Foetus and Newborn Infant" at the 1963 Annual Meeting of the British Medical Association (July 9-18).

The tetracycline group of drugs are very widely used and are generally considered to be without harmful physiologic side effects when administered in doses that are clinically efficacious for control of bacterial infections (10-25 mg/kg orally, 10-20 mg/kg parenterally). Not infrequently, however, they are used in doses greater than the maximal recommended therapeutic dose (eg, 50 mg/kg

REFERENCES

Davies, P. A.; Little, K.; and Aherne, W. A.: Lancet 1:743, 1962;.
Wallman, I. S., and Hilton, H. B.: Lancet 1:827, 1962;.
Shils, M. E.: Clin Pharmacol Ther 3:321, 1962;.
Cohlan, S. Q.; Bevelander, G.; and Tiamsic, T.: Amer J Dis Child 105:453, 1963;.
Kemp, H., and Little, K.: To be published, 1963.
Farhat, S. M.; Schelhart, D. L.; and Musselman, M M.: AMA Arch Surg 76:762, 1958;.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Davies, P. A.; Little, K.; and Aherne, W. A.: Lancet 1:743, 1962;.
Wallman, I. S., and Hilton, H. B.: Lancet 1:827, 1962;.
Shils, M. E.: Clin Pharmacol Ther 3:321, 1962;.
Cohlan, S. Q.; Bevelander, G.; and Tiamsic, T.: Amer J Dis Child 105:453, 1963;.
Kemp, H., and Little, K.: To be published, 1963.
Farhat, S. M.; Schelhart, D. L.; and Musselman, M M.: AMA Arch Surg 76:762, 1958;.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.